Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Luca Triggiani"'
Autor:
Marco Bergamini, Alberto Dalla Volta, Carlotta Palumbo, Stefania Zamboni, Luca Triggiani, Manuel Zamparini, Marta Laganà, Luca Rinaudo, Nunzia Di Meo, Irene Caramella, Roberto Bresciani, Francesca Valcamonico, Paolo Borghetti, Andrea Guerini, Davide Farina, Alessandro Antonelli, Claudio Simeone, Gherardo Mazziotti, Alfredo Berruti
Publikováno v:
eLife, Vol 13 (2024)
Background: Among its extragonadal effects, follicle-stimulating hormone (FSH) has an impact on body composition and bone metabolism. Since androgen deprivation therapy (ADT) has a profound impact on circulating FSH concentrations, this hormone could
Externí odkaz:
https://doaj.org/article/50ac1264ff7446438ea476f89523064c
Autor:
Marco Lorenzo Bonù, Gloria Pedersoli, Jacopo Balduzzi, Mariateresa Cefaratti, Eneida Mataj, Gianluca Cossali, Lorenzo Granello, Navdeep Singh, Vittorio Morelli, Davide Tomasini, Francesco Frassine, Paola Vitali, Fabrizia Terraneo, Luca Triggiani, Michela Buglione, Stefano Maria Magrini
Publikováno v:
Radiation, Vol 3, Iss 2, Pp 98-109 (2023)
Background: Stereotactic Radiotherapy (SRT) in pancreatic and biliary tract cancer (PBC) suffers from proximity to any organ(s) at risk (OARs). Some strategies to manage this issue have previously been proposed, such as Simultaneous Integrated Protec
Externí odkaz:
https://doaj.org/article/d9c35310b4d044cc8e45eb92a8d3b594
Autor:
Salvatore Cozzi, Lilia Bardoscia, Masoumeh Najafi, Sefik Igdem, Luca Triggiani, Stefano Maria Magrini, Andrea Botti, Ferran Guedea, Laura Melocchi, Patrizia Ciammella, Cinzia Iotti, Cristina Gutierrez
Publikováno v:
Current Urology, Vol 16, Iss 4, Pp 218-226 (2022)
Abstract. Objective. The aim of the study is to evaluate clinical features and outcomes after different therapeutic strategies for ductal prostate adenocarcinoma (DPC), a rare but aggressive subtype of invasive prostate cancer (PCa) accounting for, i
Externí odkaz:
https://doaj.org/article/c15a6f98b3794413a44182164cb0a30d
Autor:
Elena Verzoni, Giovanni Pappagallo, Filippo Alongi, Stefano Arcangeli, Giulio Francolini, Daniele Galanti, Luca Galli, Marco Maruzzo, Sabrina Rossetti, Giambattista Siepe, Luca Triggiani, Paolo Andrea Zucali, Rolando Maria D’Angelillo
Publikováno v:
Current Oncology, Vol 29, Iss 7, Pp 4578-4586 (2022)
Metastatic hormone-sensitive prostate cancer (mHSPC) is usually categorized as high- or low-volume disease. This is relevant because low- and high-volume metastatic disease are associated with different outcomes, and thus management of the two forms
Externí odkaz:
https://doaj.org/article/66ea5b81bf454cecadc292e1cf792f2b
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/a844cf71d1d040f7abefa8d934247e50
Autor:
Marco Lorenzo Bonù, Salvatore La Mattina, Navdeep Singh, Cristian Toraci, Luigi Spiazzi, Fabrizia Terraneo, Fernando Barbera, Paola Vitali, Francesco Frassine, Andrea Guerini, Luca Triggiani, Davide Tomasini, Vittorio Morelli, Jessica Imbrescia, Jacopo Andreuccetti, Barbara Frittoli, Frida Pittiani, Luigi Grazioli, Nazario Portolani, Luca Nicosia, Domenico Albano, Francesco Bertagna, Stefano Maria Magrini, Michela Buglione
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionRadiochemotherapy (RCHT) for the treatment of anal squamous cell carcinoma (ASCC) has evolved dramatically, also thanks to intensity-modulated RT (IMRT) and 3D image guidance (3D IGRT). Despite most patients presenting fair outcomes, unme
Externí odkaz:
https://doaj.org/article/62d094b0bb894373bf41436842ab4ae4
Autor:
Michela Buglione, Luigi Spiazzi, Andrea Emanuele Guerini, Fernando Barbera, Nadia Pasinetti, Ludovica Pegurri, Luca Triggiani, Davide Tomasini, Diana Greco, Gianluca Costantino, Alessandra Bragaglio, Nadia Bonometti, Mara Liccioli, Lorella Mascaro, Radiation Oncology Department Staff, Filippo Alongi, Stefano Maria Magrini
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-12 (2020)
Abstract Background Coronavirus Disease 2019 (COVID-19) pandemic had an overwhelming impact on healthcare worldwide. Outstandingly, the aftermath on neoplastic patients is still largely unknown, and only isolated cases of COVID-19 during radiotherapy
Externí odkaz:
https://doaj.org/article/94d727ff7be94b868d81dff92a86e2fd
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Immune checkpoint inhibitors have gained an established role in the treatment of different tumors. Indeed, their use has dramatically changed the landscape of cancer care, especially for tumor types traditionally known to have poor outcomes. However,
Externí odkaz:
https://doaj.org/article/73b2a88a831c4ef8bee72e3539bc5c81
Autor:
Silvia Codenotti, Daniela Zizioli, Luca Mignani, Sara Rezzola, Giovanna Tabellini, Silvia Parolini, Arianna Giacomini, Michela Asperti, Maura Poli, Delia Mandracchia, Marika Vezzoli, Simona Bernardi, Domenico Russo, Stefania Mitola, Eugenio Monti, Luca Triggiani, Davide Tomasini, Stefano Gastaldello, Matteo Cassandri, Rossella Rota, Francesco Marampon, Alessandro Fanzani
Publikováno v:
Cells, Vol 11, Iss 18, p 2859 (2022)
In pediatric rhabdomyosarcoma (RMS), elevated Akt signaling is associated with increased malignancy. Here, we report that expression of a constitutively active, myristoylated form of Akt1 (myrAkt1) in human RMS RD cells led to hyperactivation of the
Externí odkaz:
https://doaj.org/article/53f88aa7bd2f418f81b3c269dfdb9607
Autor:
Antonella Colosini, Simona Bernardi, Chiara Foroni, Nadia Pasinetti, Andrea Emanuele Guerini, Domenico Russo, Roberto Bresciani, Cesare Tomasi, Stefano Maria Magrini, Lilia Bardoscia, Luca Triggiani
Publikováno v:
Biomedicines, Vol 10, Iss 6, p 1321 (2022)
We propose a pilot, prospective, translational study with the aim of identifying possible molecular markers underlying metastatic prostate cancer (PC) evolution with the use of liquid biopsy. Twenty-eight castrate sensitive, oligometastatic PC patien
Externí odkaz:
https://doaj.org/article/0da0178f63c7464980ab139451cc51cb